Vimarsana
Biggest News Aggregation in the World

Page 6 - Controlled Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Controlled Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Controlled Trial Today - Breaking & Trending Today

Tongkat Ali: Benefits, Side Effects And Dosage - Vimarsana News

Tongkat Ali: Benefits, Side Effects And Dosage

Tongkat Ali: Benefits, Side Effects And Dosage

Source: forbes.com
Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years - Vimarsana News

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

/PRNewswire/ -- Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTindâ„¢...

Pictures of Best Foods to Eat as You Age - Vimarsana News

Pictures of Best Foods to Eat as You Age

Getting older is a part of life. These foods will help you do so gracefully -- and in great health!

Source: webmd.com
ENLIVEN: Pegozafermin Could Reduce Improve Fibrosis in NASH - Vimarsana News

ENLIVEN: Pegozafermin Could Reduce Improve Fibrosis in NASH

Pegozafermin was associated with improvements in fibrosis and could contribute to a resolution of NASH, according to the results of the phase 2b ENLIVEN trial.

Data from 89bio's ENLIVEN Phase 2b Trial of Pegozafermin in Patients with Nonalcoholic Steatohepatitis (NASH) Published in The New England Journal of Medicine and Simultaneously Presented in a Late-breaker Session at the EASL International Liver Congress - Vimarsana News

Data from 89bio's ENLIVEN Phase 2b Trial of Pegozafermin in Patients with Nonalcoholic Steatohepatitis (NASH) Published in The New England Journal of Medicine and Simultaneously Presented in a Late-breaker Session at the EASL International Liver Congress

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant changes on both primary histology endpoints – – New data showed pegozafermin resulted in sig...